However, some papers have shown that coagulation defects of PT-INR or aPTT are inadequate to reflect the balance of coagulation due to the rebalancing of coagulation with increased von Willebrand factor and factor VIII, and decreased natural anticoagulant proteins in patients with end-stage liver disease [30,31,32,33]. This evidence concerns the gene VWF and End Stage Liver Disease.